PSA vs EXR vs PLD
161 measures in 16 categories, one definition each, computed from filings and market data.
EXR46.6
Extra Space Storage Inc.
Real Estate · REIT - Industrial
$139.61 +1.39%$29.5B mkt cap
Score DNA
Price, rebased to 100 three years ago
PSA EXR PLD · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 0 | 0 |
| Last Congress purchase | 2026-03-27 | — | — |
| 13F net change in holders | +39 | +37 | +62 |
| ETFs adding shares, 30d | 1,037 | 978 | 1,347 |
| ETFs trimming, 30d | 800 | 769 | 1,052 |
| Net ETF funds, 30d | +237 | +209 | +295 |
Valuation
16 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| P/E (TTM) | 27.3x
40th
|
30.8x
70th
|
28.4x
60th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | 3.07
50th
|
| Price / sales | 11.4x
71st
|
8.6x
50th
|
13.0x
86th
|
| Price / book | 6.1x
100th
|
2.2x
71st
|
2.2x
64th
|
| Price / tangible book | 6.3x
100th
|
2.4x
50th
|
2.4x
57th
|
| Price / free cash flow | 17.5x
46th
|
16.7x
31st
|
22.8x
69th
|
| Price / operating cash flow | 17.6x
71st
|
15.5x
43rd
|
22.8x
93rd
|
| Enterprise value | $65.7B
93rd
|
$43.2B
86th
|
$154.2B
100th
|
| EV / sales | 13.4x
57th
|
12.6x
50th
|
16.8x
93rd
|
| EV / EBITDA | 19.4x
85th
|
13.7x
15th
|
18.5x
69th
|
| EV / EBIT | 29.6x
67th
|
17.8x
8th
|
27.5x
58th
|
| EV / free cash flow | 20.6x
8th
|
24.5x
31st
|
29.4x
62nd
|
| Earnings yield | 3.7%
71st
|
3.2%
50th
|
3.5%
57th
|
| FCF yield | 5.7%
57th
|
6.0%
71st
|
4.4%
36th
|
| Operating cash flow yield | 5.7%
29th
|
6.4%
57th
|
4.4%
7th
|
| Graham number (per share) | $116.48
100th
|
$76.71
70th
|
$74.46
60th
|
Profitability (TTM)
12 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Gross margin | 60.4%
79th
|
23.0%
50th
|
21.7%
43rd
|
| EBITDA margin | 69.1%
31st
|
92.2%
92nd
|
90.9%
85th
|
| Operating margin | 48.3%
93rd
|
43.4%
86th
|
38.4%
43rd
|
| EBIT margin | 45.3%
57th
|
71.0%
93rd
|
61.1%
71st
|
| Net margin | 41.8%
71st
|
28.0%
43rd
|
45.8%
79th
|
| NOPAT margin | 48.5%
93rd
|
34.3%
43rd
|
36.1%
50th
|
| FCF margin | 65.1%
86th
|
51.5%
64th
|
57.0%
79th
|
| Operating cash flow margin | 64.9%
79th
|
55.5%
43rd
|
57.0%
64th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 3.2%
7th
|
5.1%
29th
|
2.8%
0th
|
| Stock comp / revenue | 0.9%
14th
|
1.1%
21st
|
2.2%
71st
|
| Effective tax rate | -0.4%
0th
|
21.0%
71st
|
6.2%
64th
|
Returns on capital
11 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| ROE (on average equity) | 22.0%
100th
|
7.1%
50th
|
7.9%
64th
|
| ROA | 10.1%
100th
|
3.2%
43rd
|
4.2%
57th
|
| ROIC | 12.4%
100th
|
4.4%
57th
|
3.7%
43rd
|
| ROCE | 11.4%
100th
|
8.8%
86th
|
5.7%
43rd
|
| Return on tangible assets | 10.9%
100th
|
8.2%
86th
|
5.7%
50th
|
| Cash ROIC (OCF / invested capital) | 16.6%
100th
|
7.0%
64th
|
5.9%
36th
|
| Gross profitability (GP / assets) | 14.7%
100th
|
2.7%
36th
|
2.6%
29th
|
| ROIC, 3-yr average | 12.1%
100th
|
3.5%
33rd
|
3.8%
42nd
|
| ROIC, 5-yr average | 16.1%
100th
|
6.7%
67th
|
4.8%
42nd
|
| ROE, 5-yr average | 25.7%
100th
|
14.6%
92nd
|
7.3%
50th
|
| Incremental ROIC | -125.0%
14th
|
172.9%
100th
|
2.8%
57th
|
Growth
17 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Revenue growth (TTM YoY) | 3.0%
50th
|
1.5%
36th
|
7.3%
64th
|
| Revenue growth (QoQ) | 1.2%
50th
|
2.1%
71st
|
5.6%
100th
|
| Revenue CAGR, 3 yr | 3.7%
42nd
|
18.4%
92nd
|
6.0%
50th
|
| Revenue CAGR, 5 yr | 9.6%
25th
|
18.6%
83rd
|
15.4%
75th
|
| Gross profit CAGR, 3 yr | -3.5%
70th
|
-20.9%
30th
|
-23.0%
20th
|
| Operating income CAGR, 3 yr | 1.0%
67th
|
11.4%
92nd
|
-1.7%
50th
|
| Net income growth (TTM YoY) | 12.9%
56th
|
-1.9%
22nd
|
22.0%
67th
|
| Net income CAGR, 3 yr | -21.8%
0th
|
5.2%
56th
|
8.6%
78th
|
| EPS growth (TTM YoY) | 12.5%
56th
|
-5.6%
22nd
|
21.8%
67th
|
| EPS CAGR, 3 yr | -21.9%
0th
|
-8.8%
11th
|
9.3%
78th
|
| EPS CAGR, 5 yr | 6.0%
44th
|
-1.0%
11th
|
16.7%
89th
|
| FCF growth (TTM YoY) | 13.0%
62nd
|
-6.3%
15th
|
1.3%
46th
|
| FCF CAGR, 3 yr | 4.4%
22nd
|
13.4%
89th
|
5.8%
44th
|
| Operating cash flow CAGR, 3 yr | -0.7%
8th
|
15.7%
75th
|
2.9%
33rd
|
| Book value CAGR, 3 yr | -3.0%
33rd
|
38.4%
100th
|
0.7%
67th
|
| Dividend CAGR, 3 yr | 7.7%
75th
|
-13.4%
0th
|
2.8%
67th
|
| Sustainable growth rate | -9.0%
0th
|
-3.1%
50th
|
0.6%
80th
|
Margin history & stability
7 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Gross margin, 3-yr average | 69.1%
67th
|
58.3%
25th
|
59.4%
33rd
|
| Operating margin, 3-yr average | 48.0%
75th
|
41.9%
33rd
|
45.0%
67th
|
| Net margin, 3-yr average | 41.6%
75th
|
27.3%
33rd
|
40.8%
67th
|
| FCF margin, 3-yr average | 61.3%
92nd
|
54.0%
58th
|
58.0%
83rd
|
| Revenue stability (0-1) | 0.87
42nd
|
0.89
50th
|
0.91
58th
|
| Earnings stability (0-1) | 0.00
0th
|
0.62
83rd
|
0.48
42nd
|
| Margin stability (0-1) | 0.92
92nd
|
0.64
33rd
|
0.69
42nd
|
Liquidity (latest quarter)
7 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Cash & short-term investments | $259.9M
86th
|
$695.2M
93rd
|
$1.8B
100th
|
| Net cash (− = net debt) | −$9.9B
14th
|
−$13.7B
7th
|
−$34.7B
0th
|
| Working capital | −$216.8M
50th
|
−$1.4B
7th
|
−$764.6M
14th
|
| Current ratio | 0.67
43rd
|
0.34
14th
|
0.70
57th
|
| Quick ratio | 0.67
43rd
|
0.34
14th
|
0.70
57th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.40
57th
|
0.34
50th
|
0.70
71st
|
| Defensive interval (days) | 268 days
14th
|
— | — |
Leverage & solvency (latest quarter)
13 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Total debt | $10.2B
86th
|
$14.4B
93rd
|
$36.4B
100th
|
| Debt / equity | 1.11
79th
|
1.09
71st
|
0.68
29th
|
| Net debt / equity | 1.08
79th
|
1.03
71st
|
0.65
29th
|
| Debt / assets | 50.6%
79th
|
48.6%
71st
|
36.1%
29th
|
| Debt / capital | 52.6%
79th
|
52.1%
71st
|
40.4%
29th
|
| Debt / EBITDA | 3.01
23rd
|
4.56
46th
|
4.36
38th
|
| Net debt / EBITDA | 2.93
23rd
|
4.34
46th
|
4.15
38th
|
| Interest coverage (EBIT / interest) | 6.8x
86th
|
1.6x
36th
|
5.4x
71st
|
| Cash interest coverage | 9.7x
93rd
|
1.3x
7th
|
5.0x
64th
|
| Debt payback (years of OCF) | 3.2 yrs
7th
|
7.6 yrs
71st
|
7.0 yrs
50th
|
| Liabilities / assets | 53.8%
79th
|
52.2%
64th
|
42.5%
29th
|
| IS credit model rating | A+ | B+ | BBB- |
| Implied credit spread (bps) | 125
14th
|
650
57th
|
350
36th
|
Efficiency
11 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Asset turnover | 0.24
86th
|
0.12
50th
|
0.09
21st
|
| Fixed asset turnover | 0.26
42nd
|
4.68
67th
|
0.11
17th
|
| Inventory turnover | — | — | — |
| Receivables turnover | 56.4
92nd
|
4.1
17th
|
— |
| Days sales outstanding | 6 days
21st
|
90 days
86th
|
0 days
0th
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 0 days
0th
|
61 days
36th
|
71 days
50th
|
| Cash conversion cycle (days) | 6 days
64th
|
29 days
79th
|
−71 days
29th
|
| Capex / revenue | — | 4.0%
46th
|
0.0%
0th
|
| Capex / depreciation | — | 0.19
54th
|
0.00
0th
|
| Operating expense ratio | 34.2%
64th
|
5.4%
0th
|
— |
Cash flow & earnings quality
7 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Operating cash flow / net income | 1.55
40th
|
1.98
80th
|
1.25
10th
|
| FCF / net income | 1.56
50th
|
1.84
80th
|
1.25
30th
|
| FCF / operating cash flow | — | 92.7%
62nd
|
100.0%
85th
|
| Capex / operating cash flow | — | 7.3%
38th
|
0.0%
0th
|
| Accruals ratio | -5.5%
21st
|
-3.2%
64th
|
-1.0%
93rd
|
| Sloan accruals ratio | -9.2%
21st
|
-9.4%
14th
|
-2.7%
57th
|
| Earnings quality score (0-1) | 0.75
10th
|
1.00
20th
|
1.00
20th
|
Scores & forensic checks
15 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| IS score | 72
93rd
|
47
36th
|
64
71st
|
| IS profitability | 88
100th
|
64
50th
|
56
43rd
|
| IS growth | 52
50th
|
38
36th
|
60
57th
|
| IS value | 45
14th
|
47
29th
|
49
43rd
|
| IS momentum | 80
71st
|
70
50th
|
87
79th
|
| IS risk (safety) | 90
86th
|
30
50th
|
50
71st
|
| IS quality | 81
86th
|
70
43rd
|
75
64th
|
| IS balance sheet | 49
79th
|
36
36th
|
49
71st
|
| IS earnings quality | 85
71st
|
94
93rd
|
98
100th
|
| IS cash flow | 83
93rd
|
73
50th
|
74
71st
|
| Piotroski F-score (0-9) | 6
64th
|
4
7th
|
6
64th
|
| Altman Z-score | 3.6
93rd
|
1.5
57th
|
2.1
71st
|
| Beneish M-score | −3.23
21st
|
−3.28
14th
|
−0.83
79th
|
| Ohlson O-score | −8.41
29th
|
−7.99
36th
|
−9.33
7th
|
| IS credit score | 79
86th
|
30
43rd
|
55
64th
|
Size (TTM)
8 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| Market cap | $55.7B
93rd
|
$29.5B
86th
|
$119.5B
100th
|
| Revenue | $4.9B
86th
|
$3.4B
79th
|
$9.2B
100th
|
| EBITDA | $3.4B
93rd
|
$3.2B
86th
|
$8.4B
100th
|
| Net income | $2.0B
93rd
|
$957.8M
86th
|
$4.2B
100th
|
| Free cash flow | $3.2B
93rd
|
$1.8B
86th
|
$5.2B
100th
|
| Total assets | $20.1B
86th
|
$29.7B
93rd
|
$101.0B
100th
|
| Shareholders' equity | $9.2B
86th
|
$13.3B
93rd
|
$53.7B
100th
|
| Employees | 5,770
77th
|
8,393
85th
|
2,802
62nd
|
Price performance
9 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| 1 day | +1.0% | +1.4% | −1.0% |
| 1 week | +2.9% | +3.7% | −2.9% |
| 1 month | −0.8% | +0.4% | −7.0% |
| 3 months | −5.5% | −5.2% | −14.8% |
| 6 months | −3.5% | −4.0% | −13.4% |
| Year to date | +15.4% | +6.6% | −2.6% |
| 1 year | +0.2% | −5.3% | +3.2% |
| 3 years, cumulative | +18.5% | +25.9% | +20.4% |
| 5 years, cumulative | +20.8% | −3.2% | +10.7% |
Technicals
4 measures| Measure | PSA | EXR | PLD |
|---|---|---|---|
| RSI 14 | 58.2 | 60.5 | 34.1 |
| From 52-week high | −11.1% | −12.1% | −18.0% |
| From 52-week low | +16.3% | +12.4% | +5.4% |
| Beta | 0.93 | 1.17 | 1.32 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17